Currently, there are no pharmaceutical medications that will directly increase the rate of thoughts in patients with<unk>  experience. The treatments for Parkinson's Disease have been imposed as a model for treatment of<unk>  as in some cases the researchers have been able to treat the condition in patients suffering from Parkinson's. Steroid therapy During the time of the encephalitis lethargica period, the rise of<unk>  was seen in many of the cases. In one case in Russia it was believed that this condition could be treated with steroid therapy after the patient's condition had improved after three months using steroid. In another more recent case, an 80 year old woman had been diagnosed with Cerebral Amyloid Angiopathy (CAA) and was described to have symptoms of<unk>  after showing abnormalities within the pre-frontal cortex of the brain through a magnetic resonance imaging system (MRI) that had shown a significant increase in lesions. The patient had been put on steroid therapy which researchers McHugh et al had found a significant improvement of cognitive abilities over time. The effectiveness of steroid therapy had been observed within an MRI improvement as the number of lesions had decreased as well as the shift in behaviours of participants. L-DOPA and carbidopa regimen In one trial it was found that<unk>  as well as bradykinesia, could be treated using the combination of a L-DOPA and carbidopa regimen. This combination was believed to alter these effects of Parkinson's disease. In the short term, this combination had brought positive results as behaviours of these patients had improved. Yet these researchers found that in the long-term this combination provided a reverse effect, accelerating the cognitive slowing of the brain<unk>  and motor movement (bradykinesia). H2 antagonists H2 antagonists is a class of drugs that was found to provide positive outcomes throughout the treatment of Parkinson's disease. Some studies have shown that through oral admission, the H-2 antagonist will target specific receptors in the brain by crossing the blood-brain barrier and will alter the rate of cognitive thought processing. Psychiatrist Kaminski found an improvement of this condition in Parkinson's disease with a positive correlation between the decrease of time in cognitive thought processing and the decrease in reaction time for tasks to be completed.
Bradyphrenia
Papular eruption of blacks
Pachyonychia congenita
Steatopygia
Dandruff
Tinea imbricata
Koilonychia
Dolichonychia